RNS Number : 2799C
NetScientific PLC
27 June 2016



("NetScientific" or the "Company" or the "Group")


Grant of Options to Director


London, UK - 27th June 2016 - NetScientific plc ("NetScientific", AIM: NSCI), the transatlantic biomedical and healthcare technology group, today announced that on 24th June 2016, options over ordinary shares of 5p each were granted to Ian Postlethwaite and Stephen Smith as detailed below.

Ian Postlethwaite joined the Company on the 13th June 2016 as Chief Financial Officer, joining the Board immediately following the Company's Annual General Meeting on 15th June 2016. Stephen Smith joined the Company on 17th of February 2016 as a Non-Executive Director.



   Number of Options

Number of Options

Ian Postlethwhaite



Stephen Smith




The options have an exercise price of 79.70 pence per share, being the average closing price for the ordinary shares over the five dealing days prior to the date on which the options were granted. The options granted to Ian Postlethwaite and Stephen Smith vest on 13th June 2019 and 17th February 2019 respectively, being three years from the dates they joined the Company.



- Ends -



For more information, please contact:



François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO



Tel: +44 (0)20 3514 1800

Investec (NOMAD and broker)

Gary Clarence / Daniel Adams

Tel: +44 (0)20 7597 4000


Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton


Tel: +44 (0)20 3709 5700




About NetScientific Plc


NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.  For more information, please visit the website at www.netscientific.net.

This information is provided by RNS
The company news service from the London Stock Exchange